Peter Sallstig
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
Papers in
-
- Urticaria and Related Conditions 6
-
- Gout, Hyperuricemia, Uric Acid 7
- Co-authors
- Naomi Schlesinger (7 shared papers)Udayasankar Arulmani (7 shared papers)Marc De Meulemeester (4 shared papers)Dominik Richard (4 shared papers)A. Pikhlak (4 shared papers)Alexander So (5 shared papers)V. Murphy (5 shared papers)Eftal Yücel (4 shared papers)
- Journals
- Journal of Allergy and Clinical Immunology (2 papers)Osteoarthritis and Cartilage (2 papers)Clinical Rheumatology (1 paper)Ophthalmology (1 paper)Journal of Clinical Hypertension (1 paper)
- Partner nations
- SwitzerlandUnited StatesTürkiye
In The Last Decade
Peter Sallstig
16 papers receiving 728 citations
Peers
Comparison fields: 5 of 66
- Nephrology 380
- Ophthalmology 178
- Rheumatology 252
- Radiology, Nuclear Medicine and Imaging 133
- Hematology 62
Countries citing papers authored by Peter Sallstig
This map shows the geographic impact of Peter Sallstig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sallstig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sallstig more than expected).
Fields of papers citing papers by Peter Sallstig
This network shows the impact of papers produced by Peter Sallstig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sallstig. The network helps show where Peter Sallstig may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Sallstig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 226 | |
| 2 | 2017 | 179 | |
| 3 | 2011 | 175 | |
| 4 | 2011 | 109 | |
| 5 | 2007 | 17 | |
| 6 | 2008 | 17 | |
| 7 | 2011 | 11 | |
| 8 | OSPREY trial: randomized, active-controlled, phase II study to evaluate safety and efficacy of RTH258, a humanized single-chain anti-VEGF antibody fragment, in patients with neovascular AMD | 2015 | 7 |
| 9 | 2011 | 7 | |
| 10 | 2008 | 5 | |
| 11 | 2006 | 5 | |
| 12 | Canakinumab (ACZ885) vs triamcinolone acetonide for treatment of acute flares and prevention of recurrent flares in gouty arthritis patients refractory to or contraindicated to nsaids and/or colchicine. | 2010 | 4 |
| 13 | A 2-year study comparing the efficacy and safety of brolucizumab vs aflibercept in subjects with neovascular age-related macular degeneration: testing an alternative treatment regimen | 2016 | 4 |
| 14 | 2011 | 3 | |
| 15 | 2006 | 3 | |
| 16 | 2011 | 1 |
About Peter Sallstig
Peter Sallstig is a scholar working on Rheumatology, Nephrology, Pharmacology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 773 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (7 papers), Urticaria and Related Conditions (6 papers), Inflammatory mediators and NSAID effects (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Case Reports on Hematomas (2 papers), Inflammasome and immune disorders (2 papers), Retinal Diseases and Treatments (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Nephrology (380 citations), Ophthalmology (178 citations), Rheumatology (252 citations), Radiology, Nuclear Medicine and Imaging (133 citations) and Hematology (62 citations). Peter Sallstig has collaborated with scholars based in Switzerland, United States and Türkiye. Frequent co-authors include Naomi Schlesinger, Udayasankar Arulmani, Marc De Meulemeester, Dominik Richard, A. Pikhlak, Alexander So, V. Murphy, Eftal Yücel, Andreas Weichselberger and Lawrence J. Singerman. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Osteoarthritis and Cartilage, Clinical Rheumatology, Ophthalmology and Journal of Clinical Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.